Skip to content
Coming Soon·Opens soon·Synced from source July 6, 2026

Translational Centers Using Microphysiologic Systems for Infectious Diseases

National Institutes of Health

Posted
Jun 24, 2026
Closes
No deadline published by the funder
Last verified
Jul 6, 2026

Classification and identifiers

Solicitation number
RFA-AI-28-012
Assistance listing (CFDA)
93.855

Amount

Amount not published by the funder

Who can apply

School districtsTribal governmentsNonprofits (non-501c3)County governmentsPrivate universitiesSmall business

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) seeks to advance its mission by supporting the development of human microphysiologic systems (MPS) for infectious disease research and the development of therapeutics or biological products. MPS are in vitro platforms composed of cells or tissues maintained in a microenvironment designed to mimic the physiological aspects of in vivo tissue or organ function. There is growing support for the development of MPS for basic research at NIH and regulatory pathways at the FDA with the aim of reducing the use of animals in research and generating human tissue models that can be used to study human physiological processes. However, MPS development has not focused on their use in studies of infectious diseases or for product developme...

Finding similar opportunities...